Cervical cancer is the second most common malignancy in women worldwide. In the developing world it is the leading cause of cancer death among women. The clinical development of optical technologies for screening and diagnosis holds great promise for fighting cervical cancer worldwide. The goal of this Program Project is to integrate advances in early cancer biology and optical technology to develop cost-effective screening tools to aid in early detection of cervical cancer. We have demonstrated that optical technologies have significant potential to improve cervical cancer screening in a way that can enable screening in resource poor settings. Over the last nine years, we have carried out multi-center clinical trials to rigorously evaluate the performance and cost-effectiveness of quantitative optical technologies in more than 4,000 patients. Our results show that automated quantitative imaging and analysis of cytologic smears and histopathologic specimens can objectify and improve screening and diagnosis of cervical cancer and its precursors. The goal of Project 2 is the translation of research technologies into clinically ready processes poised for evaluation in large multi-center trials. We will conduct trials to determine the technical efficacy of all instruments under study in this Program Project. Specifically, we will test: a multispectral digital colposcope (MDC) to evaluate its performance alone and as an adjunct to colposcopy in diagnosis, the screening potential of a battery-powered diagnostic imaging aid (DIA) optimized for use in low-resource settings, an in vivo confocal microscope to facilitate diagnosis by improving the selection of tissue sites for biopsy, and the quantitative imaging of contrast agents to enhance detection of cervical lesions. Instruments that are found to improve upon the sensitivity and specificity of current technology can improve patient outcomes by better guiding treatment, control costs by sparing unnecessary interventions, and improve patient participation in screening and follow-up by inspiring confidence in clinical tests. Devices that match the performance of current technology can enable cancer detection programs in low-resource settings by replacing infrastructure, moderating the need for expert personnel, or reducing procurement and operating costs of equipment.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-RPRB-7)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Brookdale University Hospital & Medical Center
United States
Zip Code
Li, Gerald; van Niekerk, Dirk; Miller, Dianne et al. (2014) Molecular fixative enables expression microarray analysis of microdissected clinical cervical specimens. Exp Mol Pathol 96:168-77
Scheurer, Michael E; Danysh, Heather E; Follen, Michele et al. (2014) Association of traffic-related hazardous air pollutants and cervical dysplasia in an urban multiethnic population: a cross-sectional study. Environ Health 13:52
Wang, Lu; Lee, Jong Soo; Lane, Pierre et al. (2014) A statistical model for removing inter-device differences in spectroscopy. Opt Express 22:7617-24
Montealegre, Jane R; Zhou, Renke; Amirian, E Susan et al. (2014) Uncovering nativity disparities in cancer patterns: Multiple imputation strategy to handle missing nativity data in the Surveillance, Epidemiology, and End Results data file. Cancer 120:1203-11
Guillaud, Martial; Buys, Timon P H; Carraro, Anita et al. (2014) Evaluation of HPV infection and smoking status impacts on cell proliferation in epithelial layers of cervical neoplasia. PLoS One 9:e107088
Montealegre, Jane R; Zhou, Renke; Amirian, E Susan et al. (2013) Nativity disparities in late-stage diagnosis and cause-specific survival among Hispanic women with invasive cervical cancer: an analysis of Surveillance, Epidemiology, and End Results data. Cancer Causes Control 24:1985-94
Yang, Jingjing; Scott, David W (2013) Robust Fitting of a Weibull Model with Optional Censoring. Comput Stat Data Anal 67:149-161
El Hallani, S; Poh, C F; Macaulay, C E et al. (2013) Ex vivo confocal imaging with contrast agents for the detection of oral potentially malignant lesions. Oral Oncol 49:582-90
Montgomery, Owen; Follen, Michele; Urdaneta-Hartmann, Sandra (2012) The 2010 Annual Sex and Gender Research Forum at Drexel University and Drexel University College of Medicine: an institute for women's health and leadership initiative. Introduction. Gend Med 9:S1-6
Pham, Bryan; Rhodes, Helen; Milbourne, Andrea et al. (2012) Epidemiologic differentiation of diagnostic and screening populations for the assessment of cervical dysplasia using optical technologies. Gend Med 9:S36-47

Showing the most recent 10 out of 90 publications